In a study published in 2017, Yan-Yu Wang et al. utilized a 42.5% cutoff expression level to divide 123 bone marrow samples from CD34 + AML patients into low and high CLL-1 expression groups [41]. Here, CLEC12A is linked to acute myeloid leukemia.